LIMENDA 750 mg + 200 mg is a combination vaginal medication containing metronidazole and miconazole nitrate. It is designed for the local treatment of mixed vaginal infections caused by susceptible bacteria, fungi, and other microorganisms.
The dual-action formula combines antibacterial, antiprotozoal, and antifungal properties, making it a commonly prescribed option for women experiencing symptoms associated with vaginal infections.
Each vaginal suppository contains:
Additional inactive ingredients help ensure proper delivery and effectiveness.
LIMENDA may be prescribed for:
Treatment should be used according to healthcare provider recommendations.
Metronidazole works against anaerobic bacteria and certain protozoa by disrupting microbial DNA synthesis.
Miconazole nitrate is an antifungal agent that inhibits the growth of Candida species and other susceptible fungi commonly associated with vaginal infections.
Together, these active ingredients provide broad-spectrum local treatment.
LIMENDA is intended for vaginal use only.
The duration and frequency of treatment should be determined by a healthcare professional according to the individual patient's condition.
Some users may experience:
Medical advice should be sought if symptoms worsen or persist.
LIMENDA is used for the local treatment of vaginal infections caused by bacteria, fungi, or mixed microorganisms.
Each suppository contains metronidazole 750 mg and miconazole nitrate 200 mg.
Yes. The miconazole component is active against Candida species commonly responsible for vaginal yeast infections.
Each package contains 7 vaginal suppositories.
Ask a question or inquire about delivery to your country
